Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan
- 31 July 2009
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 45 (7) , 589-593
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Oral squamous cell carcinoma: Review of prognostic and predictive factorsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- MALT lymphoma with t(14;18)(q32;q21)/IGH‐MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expressionThe Journal of Pathology, 2005
- Mutation analysis of theBCL10 gene in childhood solid malignanciesMedical and Pediatric Oncology, 2002
- Lack of Bcl10 gene mutations in laryngeal squamous cell carcinomaThe Journal of Laryngology & Otology, 2002
- BCL10 Expression in Normal and Neoplastic Lymphoid TissueThe American Journal of Pathology, 2000
- Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: Report of 46 casesHuman Mutation, 2000
- BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomasBritish Journal of Cancer, 1999
- Bcl10 is not a target for frequent mutation in human carcinomasBritish Journal of Cancer, 1999
- Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)Nature Genetics, 1999
- Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor TypesCell, 1999